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Abstract
Background: Mobile phone-assisted technologies provide the opportunity to optimize the feasibility of long-term blood pressure
(BP) monitoring at home, with the potential of large-scale data collection.
Objective: In this proof-of-principle study, we evaluated the feasibility of home BP monitoring using mobile phone-assisted
technology, by investigating (1) the association between study center and home BP measurements; (2) adherence to reminders
on the mobile phone to perform home BP measurements; and (3) referrals, treatment consequences and BP reduction after a raised
home BP was diagnosed.
Methods: We used iVitality, a research platform that comprises a Website, a mobile phone-based app, and health sensors, to
measure BP and several other health characteristics during a 6-month period. BP was measured twice at baseline at the study
center. Home BP was measured on 4 days during the first week, and thereafter, at semimonthly or monthly intervals, for which
participants received reminders on their mobile phone. In the monthly protocol, measurements were performed during 2 consecutive
days. In the semimonthly protocol, BP was measured at 1 day.
Results: We included 151 participants (mean age [standard deviation] 57.3 [5.3] years). BP measured at the study center was
systematically higher when compared with home BP measurements (mean difference systolic BP [standard error] 8.72 [1.08] and
diastolic BP 5.81 [0.68] mm Hg, respectively). Correlation of study center and home measurements of BP was high (R=0.72 for
systolic BP and 0.72 for diastolic BP, both P<.001). Adherence was better in participants measuring semimonthly (71.4%)
compared with participants performing monthly measurements (64.3%, P=.008). During the study, 41 (27.2%) participants were
referred to their general practitioner because of a high BP. Referred participants had a decrease in their BP during follow-up
(mean difference final and initial [standard error] −5.29 [1.92] for systolic BP and −2.93 [1.08] for diastolic BP, both P<.05).
Conclusion: Mobile phone-assisted technology is a reliable and promising method with good adherence to measure BP at home
during a 6-month period. This provides a possibility for implementation in large-scale studies and can potentially contribute to
BP reduction.
(JMIR Mhealth Uhealth 2016;4(2):e67)   doi:10.2196/mhealth.5485
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Introduction
High blood pressure contributes to the global burden of disease,
accounting for 9.4 million deaths per year [1]. With a prevalence
as high as 78% among the 65-plus population in Europe, it is
one of the most common chronic conditions in primary care [2].
Although the prevalence is predicted to further increase over
the coming years, only 70% of all hypertensive patients are
aware of having hypertension [3,4]. In spite of widely available
effective ways to reduce blood pressure, rates of hypertension
control are still far from optimal [2,5-7]. In one study including
5296 participants, blood pressure control was achieved in only
30% of patients, who were aged 60 years or older [8].
The increasing availability of the Internet, mobile phones, and
health sensors provides the potential to interactively administer
health interventions at home. Recent surveys show that at least
75% of the European population uses the Internet on a regular
basis, with almost half of them using a mobile phone to access
the Internet (smartphone) [9]. Adults aged 65 years and older
are the fastest-growing group of Internet users [10]. Older adults
have a high interest in self-assessment health tools [11]. This
enables people to measure blood pressure at home, with the
potential of direct feedback and treatment adjustments.
Furthermore, previous studies show that home blood pressure
measurements, when compared with clinic blood pressure
measurements, are in fact a stronger prognostic indicator of
cardiovascular events [12-14]. It could therefore be effective to
identify patients at risk of cardiovascular events and thereby
prevent the occurrence of cardiovascular complications [12,15].
In addition, it provides a potential for large-scale implementation
and data collection. However, data on feasibility of long-term
home blood pressure measurements, using the Internet and
mobile phones, are scarce [16-18].
The aim of this proof-of-principle study was to evaluate home
blood pressure measurements using mobile phone-assisted
technology. For this, we investigated (1) the association between
study center and home blood pressure; (2) the adherence to
perform home blood pressure measurements according to a
monthly or semimonthly measurement protocol; and (3)
referrals, treatment consequences and blood pressure reduction
after a raised home blood pressure was diagnosed.
Methods
Study Design
iVitality is a Web-based research platform that consists of a
Website, a mobile phone-based app, and sensors that are
connected with or already integrated in the mobile phone to
measure blood pressure [19]. This iVitality study is a
proof-of-principle study in which participants were randomized
to perform home blood pressure measurements according to a
monthly or semimonthly measurement protocol, during a period
of 6 months. The different measurement protocols are described
in more detail in the “Follow-Up Measurements” paragraph
below.
Study Participants
We chose to perform this study in people with a parental history
of dementia because (1) they have a higher risk of both
hypertension and dementia, making them a potentially suitable
target group for large-scale preventive studies and (2) they are
highly motivated to participate in preventive studies [13,14,15].
Other inclusion criteria were (1) age 50 years and older; (2)
familiar with and in possession of a mobile phone with iOS or
Android (version, 2.3.3 or higher) software; and (3) motivated
to measure health characteristics at home several times a month,
during a 6-month period. Exclusion criteria were a medical
diagnosis of dementia and/or any other cognitive disorder and
a medical history of stroke and/or transient ischemic attack.
Participants were recruited through advertisements in memory
outpatient clinics, nursing homes, general practices, and on the
Website, and in the newsletter of the Dutch Alzheimer
Foundation (Alzheimer-Nederland). If all of the inclusion criteria
were met, participants received detailed study information in
print. They visited the study center at Leiden University Medical
Center or Academic Medical Center Amsterdam at baseline,
where they received information about the study and baseline
measurements were performed by a study physician or research
nurse. Written informed consent was obtained from all
participants. The medical ethical committee of Leiden University
Medical Center, the Netherlands, approved the study.
Baseline Measurements
Enrolment and follow-up took place from September 2013 to
January 2015. In preparation for the first visit to the study center,
all participants completed a Web-based questionnaire on
education, medical history, and medication use. During the visit
to the study center, detailed information about the iVitality app
and instructions on how to use it were given. History of
hypertension and medication use was self-reported. Blood
pressure was measured twice at baseline on the upper left arm,
in sitting position with a fully automatic electronic blood
pressure monitor. Participants were instructed in the use of the
home blood pressure monitor.
Follow-Up Measurements
During a 6-month period, participants received automatic
messages on preprogrammed days at self-chosen time points
on their mobile phone, which reminded them to measure blood
pressure. Participants with an Android mobile phone used an
A&D blood pressure monitor (A&D Company, Ltd; model UA
767 Bluetooth) which was connected to the mobile phone and
automatically transferred the results to the iVitality app by
Bluetooth [20]. Participants with an iPhone used an OMRON
(OMRON Healthcare Company, Ltd, model M6W and M6AC
[HEM-7322-E]); they manually typed their blood pressure
values and heart rate in the iVitality app [21]. During the first
week and the last week of the study, all participants performed
blood pressure measurements according to the guideline of the
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European Society of Hypertension [13]. In short, participants
were asked to measure their blood pressure twice at both
morning and evening, at least for 4 days during the first week
of the study, with day 1 being discarded [13]. For the rest of the
study period, blood pressure was measured according to 2
different study protocols, to which participants were randomly
assigned by a computerized program at baseline. Randomization
was performed in a 1:1 manner stratified for sex. In the monthly
protocol, participants performed measurements in the morning
and evening of 2 consecutive days. In the semimonthly protocol,
blood pressure was measured in the morning and evening of
only one day. Blood pressure was measured twice at each
measurement; the mean of both measurements was used.
Reminders to perform blood pressure measurements were sent
the evening before the measurement day and at the actual day
on which the participant was expected to perform the blood
pressure measurements. When participants did not perform their
blood pressure measurements, they received a reminder the day
after. This reminder was sent automatically by the Website of
the iVitality research platform, and therefore, was a standardized
procedure. The measured blood pressure was sent as a message
to the mobile phone. Blood pressure measurements were also
graphically visible in the app. Participants with a mean systolic
home blood pressure above 135 mm Hg and/or 85 mm Hg for
diastolic home blood pressure during these days were considered
as possibly having hypertension and therefore referred to their
general practitioner (GP) [13].
Statistical Analysis
Characteristics of the study participants are reported as mean
with standard deviation for continuous variables and as number
with percentage for categorical variables. We used Pearson’s
correlation coefficient to calculate the correlation between home
and study center blood pressure measurements. To investigate
agreement between study center and home blood pressure
measurements, we computed the mean and the difference in
study center and home blood pressure measurements and
visualized this in a Bland–Altman plot.
Adherence was defined as the actual performance of all blood
pressure measurements within 1 week of the time point they
were expected to perform their measurements and for which
the participant received reminders through the mobile phone
app. For each participant, we calculated the percentage of
adherence during follow-up. Difference in adherence between
the monthly and semimonthly measurement protocol was
assessed using a Mann–Whitney U test. In this proof-of-principle
study, only participants who completed the 6-month period were
used in the primary analysis. In a sensitivity analysis, we
included all participants who were included at baseline.
We investigated the difference in blood pressure during the first
week and the final week after 6 months using a paired t -test.
For both blood pressure during the first week and final blood
pressure, we calculated the mean values of all blood pressure
measurements performed during the first and last week, with
day 1 of both weeks being discarded [13].
All analyses were performed using SPSS (version 22.0.0, SPSS
Inc., Chicago, IL, USA).
Results
Baseline characteristics
Figure 1 shows the inclusion flowchart of participants. A total
of 195 participants registered on the Web to participate. Of
those, 27 did not meet inclusion criteria and 17 registered after
recruitment had been completed because of a time lag between
registration on the Web and baseline visits. Our study population
therefore included 151 participants. A number of 66 (43.7%)
participants were assigned to perform blood pressure
measurements at a monthly interval; 85 (56.3%) participants
were assigned to perform semimonthly blood pressure
measurements (Figure 1).
Baseline characteristics are shown in Table 1. Mean age was
57.3 (standard deviation [SD] 5.3) years; 107 (70.9%)
participants were female. Of all participants, 56 (37.1%) used
iPhone and 59 (39.1%) used Samsung. Mean systolic and
diastolic blood pressure measured at the study center was 137.8
(SD 18.2) and 85.4 (SD 10.8) mm Hg, respectively. Participants
within the monthly protocol had a higher body mass index,
systolic blood pressure, and diastolic blood pressure at baseline
(Multimedia Appendix 1). A number of 32 (21.2%) participants
had a history of hypertension and used antihypertensive
medication, most commonly diuretics (15 participants [46.9%
of hypertensive participants]). This did not differ between the
monthly and semimonthly protocol.
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Table 1. Baseline characteristics of iVitality participants.a,b
All participants (N=151)Demographics
57.3 (5.3)Age (years)
107 (70.9)Female, n (%)
26.4 (4.0)Body mass index




Study center, n (%)
55 (36.4)Academic Medical Center Amsterdam
96 (63.6)Leiden University Medical Center






137.8 (18.2)Systolic blood pressure (mm Hg)
85.4 (10.8)Diastolic blood pressure (mm Hg)
67.2 (10.2)Heart rate (bpm)
Vascular risk factors, n (%)
32 (21.2)History of hypertension
2 (1.3)History of diabetes mellitus
4 (4.6)History of MI
11 (7.3)History of arrhythmia
3 (2.0)History of heart failure
14 (9.3)Hypercholesterolemia
14 (9.3)Current smoker






No of antihypertensive medication, n (%)
21 (65.6)1
11 (34.4)2 or more
aData represent mean (standard deviation) unless stated otherwise
bAbbreviations: MI, myocardial infarction; MMSE, mini-mental state examination.
cMissing data for n=3 participants. Low: primary education, lower education, MAVO/MULO. Intermediate: high general secondary education (HAVO,
HBS), Preparatory Scientific Education (VWO), intermediate professional education (MBO). High: higher professional education (HBO), academic
education (university).
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Figure 1. Flowchart of study participants. *Reasons why participants did not meet in-/exclusion criteria were as follows: n=4 did not have the correct
software version of the mobile phone; n=6 did not have parents with dementia; n=6 were on holidays during the inclusion period; n=7 were not interested
to participate after reading the study information; n=4 because of other reasons.
Main findings
The association between study center and home blood pressure
during the first week is shown in Figure 2. The correlation
between study center and home measurements was high for
both systolic (R=0.72, P<.001) and diastolic blood pressure
(R=0.72, P<.001; panel A). Systolic blood pressure at the study
center was systematically 8.72 mm Hg higher (standard error
[SE] 1.08) and diastolic blood pressure was 5.81 (0.68) mm Hg
higher when compared with home blood pressure measurements
(panel B). The Bland–Altman plot shows that the difference
between the measurements was randomly distributed over the
mean of the measurements, indicating that there was no
systematic bias in agreement between the study center and home
measurements. The 95% limits of agreement for the comparison
were −16.82 to 32.82 mm Hg for systolic blood pressure and
−9.71 to 21.33 mm Hg for diastolic blood pressure.
Adherence to the monthly and semimonthly blood pressure
measurement protocols is shown in Figure 3. In total, 12
participants did not complete follow-up: 5 (7.6%) participants
in the monthly measurement protocol and 7 (8.2%) participants
in the semimonthly measurement protocol. Median adherence
to perform blood pressure measurements was 71.4% (Figure
3). Participants performing semimonthly blood pressure
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measurements were more adherent (median adherence 71.4%)
when compared with participants performing monthly blood
pressure measurements (64.3%, P=.008). There was no
difference in adherence between participants who entered their
blood pressure measurements manually and participants who
used a Bluetooth connection to transfer the measurements (data
not shown). Furthermore, a sensitivity analysis in which we
investigated the adherence of all 151 participants who were
included at baseline, showed similar results: adherence was
higher in participants who performed semimonthly blood
pressure measurements (median adherence 85.7%) when
compared with participants performing monthly measurements
(71.4%, P=.002; Multimedia Appendix 2). Discontinuation was
highest within the first weeks of follow-up for both measurement
protocols.
Table 2 presents the difference in final and initial home blood
pressure measurements. Among all participants, there was no
difference between final and initial blood pressure, for both
systolic (mean difference [SE] −1.30 [1.10] mm Hg, P=.240)
and diastolic (−0.90 [0.51] mm Hg, P=.081) blood pressure.
There were 41 out of 151 (27.2%) participants who were referred
to their GP because of a high blood pressure, of whom 35
(85.2%) actually visited their GP. In referred participants, blood
pressure decreased significantly during the study, both systolic
(mean difference [SE] −5.29 [1.92] mm Hg, P=.011) and
diastolic (−2.93 [1.08] mm Hg, P=.012). Furthermore, no
difference was found between final and initial blood pressure
for both systolic and diastolic blood pressure between the
monthly and semimonthly protocol (data not shown). In 7 out
of 41 (17.1%) participants, blood pressure lowering medication
had been started or changed.
Table 2. Difference between the first and last home blood pressure measurement.a,b
Diastolic blood pressureSystolic blood pressure
P-valueDiff. (SE)LastFirstP-valueDiff. (SE)LastFirst




















































aData represent the mean difference (standard error) in mm Hg of final and initial blood pressure.
bDiff, difference; SE, standard error; GP, general practitioner; BP, blood pressure.
cMissing data for n=48 participants.
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Figure 2. Association between blood pressure measurements at home and in the study center. Abbreviations: R, Pearson’s correlation coefficient; SBP,
systolic blood pressure; DBP, diastolic blood pressure. Panel A shows the home blood pressure (mean of two consecutive measurements in both morning
and evening at day 2, 3 and 4, x-axis) and corresponding study center blood pressure measurements (mean value of two consecutive measurements,
y-axis) for each participant. Panel B shows the agreement between study center and home systolic and diastolic blood pressure measurements.
Figure 3. Adherence of participants to monthly and semi-monthly measurement protocol. Data represent the percentage of participants who are adherent
to perform the expected blood pressure measurements.
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This proof-of-principle study, in which we evaluated the
feasibility of home blood pressure measurements during a
6-month intervention period using mobile phone-assisted
technology, has 3 main findings. First, study center and home
blood pressure were highly correlated, although blood pressure
measured at the study center was systematically higher when
compared with home blood pressure. Second, adherence of all
participants to perform blood pressure measurements was high
and persisted during 6 months with better adherence in
participants measuring semimonthly compared with participants
who performed monthly measurements. Third, in participants
who were referred to their GP because of a high blood pressure,
systolic and diastolic blood pressure decreased significantly
during the study, especially for those who started medication.
Our finding that systolic and diastolic blood pressure at the
study center was systematically higher when compared with
home blood pressure measurements is in line with previous
literature [22]. A well-known explanation for this is the
“white-coat effect,” meaning that blood pressure is higher
because of stress and anxiety that patients experience during a
clinical setting [22,23]. Literature shows that home blood
pressure measurements, instead of office or clinic blood pressure
measurements, are in fact a stronger prognostic indicator of
cardiovascular events and even have their own (lower) reference
values [12-14]. A participant-level meta-analysis including 5008
participants (mean age 57 years, not treated with
antihypertensive medication), showed that in participants with
an optimal office blood pressure (<120/<80 mm Hg), a 10-mm
Hg higher systolic home blood pressure increased the risk of
any cardiovascular event by nearly 30% [12]. In addition,
previous studies on cost-effectiveness show that compared with
usual care, home blood pressure monitoring is very useful for
reducing health care costs. In view of the low burden of
measuring and established treatment options, home blood
pressure monitoring could therefore be an important strategy
to further prevent cardiovascular complications, especially in
people at risk [13].
Previous studies on adherence to perform home blood pressure
measurements show similar results to our findings [17,24]. In
a study on telemonitoring including 213 hypertensive patients,
who were asked to measure their blood pressure at least 6 times
a week during 6 months, mean adherence was 73% [17]. Another
study including only patients with heart failure (mean age 61
years) showed adherence of 55% [24]. Furthermore, in this
study, we found that participants using the semimonthly
measurement protocol showed higher adherence compared with
participants using the monthly measurement protocol. A possible
explanation could be that the fact that participants received a
reminder twice a month (instead of once a month), might have
kept participants more engaged in the study and therefore
increased their adherence [19]. Furthermore, the burden of
measuring for 1 day every 2 weeks may have been perceived
lower than measuring during 2 consecutive days, albeit with
monthly intervals.
Home-based blood pressure measurements using mobile
phone-based technology may have several potential
opportunities. First, other parameters derived from repeated
blood pressure measurements, can easily be calculated,
especially in a home-based setting. An example of such a
parameter is blood pressure variability, of which we recently
showed its association with cognitive decline [25]. Second, the
combination with other parameters and measurements may
reveal additional targets for blood pressure control. Physical
activity, sleep, and other lifestyle factors can be measured using
a mobile phone. This offers the potential for interventions, for
instance aimed at increasing physical activity, that also
beneficially affect blood pressure. The iVitality platform offers
the opportunity to assess these lifestyle factors. Third, mobile
phone-based technology might be a cost-effective alternative
in the control of hypertension. It was previously shown that
ambulatory blood pressure monitoring as a diagnostic strategy
for hypertension saves costs, mainly because additional costs
from ambulatory monitoring are counterbalanced by cost savings
from better targeted treatment [26]. As mobile phone-based
technology only requires a standard blood pressure monitor,
which is much cheaper when compared with an ambulatory
blood pressure monitor, we believe it has the potential of saving
health care costs.
In our study, blood pressure was lower at the end of follow-up
when the participant was referred to the GP because of a high
blood pressure at baseline. There are 2 possible explanations
for this finding. First, the decrease in blood pressure may be the
result of regression to the mean. This phenomenon occurs when
repeated measurements tend to be followed by measurements
that are closer to the mean. Although our baseline measurements
were defined on repeated blood pressure measurements, it is
still expected that the mean blood pressure during follow-up
will go down, owing to regression toward the mean. Second, it
may reflect a true effect of monitoring and subsequent treatment
of blood pressure. Blood pressure lowering interventions by the
GP and higher awareness of participants may all have
contributed to a lower blood pressure. Although the fact that
the effect on blood pressure was highest in those who initiated
medication suggests the second explanation, we have not
collected enough information on interventions in this
proof-of-principle study to draw definite conclusions. An
adequately powered randomized controlled trial may help to
establish the effects of the interventions.
For this proof-of-principle study, we selected highly motivated
participants with a parental history of dementia. This may have
introduced a selection bias toward better adherence and
treatment effects, which reduces the external validity for other,
broader defined populations. The strength of this study is that
mobile phone technology was used to collect study data on
blood pressure. This innovative method reduces the need for
face-to-face contact and stimulates self-management. Now that
this proof-of-principle study is promising, broader and larger
populations can be included in future studies.
Conclusions
This proof-of-principle study demonstrates that mobile
phone-assisted technology can be used as a reliable and
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promising method to measure blood pressure at home during a
6-month period. This provides a possibility for implementation
in large-scale studies and can potentially lead to blood pressure





Baseline characteristics of iVitality participants, by protocol.
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Multimedia Appendix 2
Adherence of participants to monthly and semimonthly measurement protocol (all participants included).
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